{"id":382641,"date":"2020-11-17T07:03:15","date_gmt":"2020-11-17T12:03:15","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=382641"},"modified":"2020-11-17T07:03:15","modified_gmt":"2020-11-17T12:03:15","slug":"microbot-medical-secures-patents-in-multiple-global-jurisdictions","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-secures-patents-in-multiple-global-jurisdictions\/","title":{"rendered":"Microbot Medical Secures Patents in Multiple Global Jurisdictions"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">HINGHAM, Mass., Nov.  17, 2020  (GLOBE NEWSWIRE) &#8212; Microbot Medical Inc. (Nasdaq: MBOT) announced that it has received patents in multiple jurisdictions, further demonstrating the Company\u2019s continued execution of expanding and protecting its Intellectual Property (IP) portfolio. The Company now has 40 issued\/allowed patents and 23 patent applications pending worldwide.<\/p>\n<p align=\"justify\">\u201cAs we continue to make progress on the development, clinical and regulatory fronts, it is encouraging that we are also achieving our goals to broaden the protection of our novel technologies,\u201d commented Harel Gadot, CEO, President and Chairman. \u201cStrengthening our IP portfolio is a critical component of Microbot\u2019s strategy for facilitating product evolution and maximizing future commercial opportunities.\u201d<\/p>\n<p align=\"justify\">The U.S. Patent and Trademark Office (USPTO) issued a Notice of Allowance 684 pertaining to the Company\u2019s Self-Cleaning Shunt (SCS) device. The allowed patent application is a Continuation of a patent, issued on July 19, 2016, and covers a device for mitigating occlusion in an implantable catheter. The claims are directed to a device comprising a tube having at least one drainage opening disposed in its wall and configured for implantation within a body cavity, further comprising a cleaning element having at least one cleaning protrusion extending into the opening and configured to move within the opening.<\/p>\n<p align=\"justify\">Additionally, the European Patent Office (EPO) granted an EP Patent covering the Company\u2019s guidewire technology for use with endo-luminal interventions, and related to the Company\u2019s LIBERTY<sup>TM<\/sup> development. This is the second European patent granted for this unique technology and extends protection to include the device\u2019s current development, having a double guidewire comprising a first hollow guidewire and a second guidewire deployed within the first guidewire, and an adjuster mechanism operable to displace the second guidewire longitudinally relative to the first guidewire between at least three states.<\/p>\n<p>\n        <strong>About Microbot Medical<\/strong>\n      <\/p>\n<p align=\"justify\">Microbot Medical Inc. (NASDAQ: MBOT) is a pre-clinical medical device company that specializes in transformational micro-robotic technologies, focused primarily on both natural and artificial lumens within the human body. Microbot\u2019s current proprietary technological platforms provide the foundation for the development of a Multi Generation Pipeline Portfolio (MGPP).<\/p>\n<p align=\"justify\">Microbot Medical was founded in 2010 by Harel Gadot, Prof. Moshe Shoham, and Yossi Bornstein with the goals of improving clinical outcomes for patients and increasing accessibility through the use of micro-robotic technologies. Further information about Microbot Medical is available at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=f_lfpSLQXl8M35LlPA6bfhvTxIr7RznHiRhAOeCL0FTnJA5AJwVDeMpDAFR3HnwdnBfwQW_lnsIm9_p0-VPgW67bofOSThdxt-zuVSVkDN0kEu50him3dptGjOEYZoUj\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">http:\/\/www.microbotmedical.com<\/a>.<\/p>\n<p>\n        <strong>Safe Harbor<\/strong>\n      <\/p>\n<p align=\"justify\">Statements pertaining to the registered direct offering, timing, the amount and anticipated use of proceeds and statements pertaining to future financial and\/or operating results, future growth in research, technology, clinical development, and potential opportunities for Microbot Medical Inc. and its subsidiaries, along with other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management, constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and the Federal securities laws. Any statements that are not historical fact (including, but not limited to statements that contain words such as \u201cwill,\u201d \u201cbelieves,\u201d \u201cplans,\u201d \u201canticipates,\u201d \u201cexpects\u201d and \u201cestimates\u201d) should also be considered to be forward-looking statements. Forward-looking statements involve risks and uncertainties, including, without limitation, market conditions and the satisfaction of customary closing conditions, risks inherent in the development and\/or commercialization of potential products, including LIBERTY<sup>TM<\/sup>, the outcome of its studies to evaluate the SCS and other existing and future technologies, uncertainty in the results of pre-clinical and clinical trials or regulatory pathways and regulatory approvals, uncertainty resulting from the COVID-19 pandemic, need and ability to obtain future capital, and maintenance of intellectual property rights. Additional information on risks facing Microbot Medical can be found under the heading \u201cRisk Factors\u201d in Microbot Medical\u2019s periodic reports filed with the Securities and Exchange Commission (SEC), which are available on the SEC\u2019s web site at www.sec.gov. Microbot Medical disclaims any intent or obligation to update these forward-looking statements, except as required by law.<\/p>\n<p>\n        <strong>Investor Contact: <\/strong>\n      <\/p>\n<p>Michael Polyviou<br \/>EVC Group<br \/>mpolyviou@evcgroup.com<br \/>732-933-2754<\/p>\n<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NzEzNyMzODMwMTg5IzIwODIxMTE=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/95f6cef4-8f44-4ac3-806a-620f4c6a7560\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>HINGHAM, Mass., Nov. 17, 2020 (GLOBE NEWSWIRE) &#8212; Microbot Medical Inc. (Nasdaq: MBOT) announced that it has received patents in multiple jurisdictions, further demonstrating the Company\u2019s continued execution of expanding and protecting its Intellectual Property (IP) portfolio. The Company now has 40 issued\/allowed patents and 23 patent applications pending worldwide. \u201cAs we continue to make progress on the development, clinical and regulatory fronts, it is encouraging that we are also achieving our goals to broaden the protection of our novel technologies,\u201d commented Harel Gadot, CEO, President and Chairman. \u201cStrengthening our IP portfolio is a critical component of Microbot\u2019s strategy for facilitating product evolution and maximizing future commercial opportunities.\u201d The U.S. Patent and Trademark Office (USPTO) issued a Notice of Allowance &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-secures-patents-in-multiple-global-jurisdictions\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Microbot Medical Secures Patents in Multiple Global Jurisdictions&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-382641","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Microbot Medical Secures Patents in Multiple Global Jurisdictions - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-secures-patents-in-multiple-global-jurisdictions\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Microbot Medical Secures Patents in Multiple Global Jurisdictions - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"HINGHAM, Mass., Nov. 17, 2020 (GLOBE NEWSWIRE) &#8212; Microbot Medical Inc. (Nasdaq: MBOT) announced that it has received patents in multiple jurisdictions, further demonstrating the Company\u2019s continued execution of expanding and protecting its Intellectual Property (IP) portfolio. The Company now has 40 issued\/allowed patents and 23 patent applications pending worldwide. \u201cAs we continue to make progress on the development, clinical and regulatory fronts, it is encouraging that we are also achieving our goals to broaden the protection of our novel technologies,\u201d commented Harel Gadot, CEO, President and Chairman. \u201cStrengthening our IP portfolio is a critical component of Microbot\u2019s strategy for facilitating product evolution and maximizing future commercial opportunities.\u201d The U.S. Patent and Trademark Office (USPTO) issued a Notice of Allowance &hellip; Continue reading &quot;Microbot Medical Secures Patents in Multiple Global Jurisdictions&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-secures-patents-in-multiple-global-jurisdictions\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-17T12:03:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NzEzNyMzODMwMTg5IzIwODIxMTE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/microbot-medical-secures-patents-in-multiple-global-jurisdictions\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/microbot-medical-secures-patents-in-multiple-global-jurisdictions\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Microbot Medical Secures Patents in Multiple Global Jurisdictions\",\"datePublished\":\"2020-11-17T12:03:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/microbot-medical-secures-patents-in-multiple-global-jurisdictions\\\/\"},\"wordCount\":655,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/microbot-medical-secures-patents-in-multiple-global-jurisdictions\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NzEzNyMzODMwMTg5IzIwODIxMTE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/microbot-medical-secures-patents-in-multiple-global-jurisdictions\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/microbot-medical-secures-patents-in-multiple-global-jurisdictions\\\/\",\"name\":\"Microbot Medical Secures Patents in Multiple Global Jurisdictions - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/microbot-medical-secures-patents-in-multiple-global-jurisdictions\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/microbot-medical-secures-patents-in-multiple-global-jurisdictions\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NzEzNyMzODMwMTg5IzIwODIxMTE=\",\"datePublished\":\"2020-11-17T12:03:15+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/microbot-medical-secures-patents-in-multiple-global-jurisdictions\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/microbot-medical-secures-patents-in-multiple-global-jurisdictions\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/microbot-medical-secures-patents-in-multiple-global-jurisdictions\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NzEzNyMzODMwMTg5IzIwODIxMTE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA4NzEzNyMzODMwMTg5IzIwODIxMTE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/microbot-medical-secures-patents-in-multiple-global-jurisdictions\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Microbot Medical Secures Patents in Multiple Global Jurisdictions\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Microbot Medical Secures Patents in Multiple Global Jurisdictions - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-secures-patents-in-multiple-global-jurisdictions\/","og_locale":"en_US","og_type":"article","og_title":"Microbot Medical Secures Patents in Multiple Global Jurisdictions - Market Newsdesk","og_description":"HINGHAM, Mass., Nov. 17, 2020 (GLOBE NEWSWIRE) &#8212; Microbot Medical Inc. (Nasdaq: MBOT) announced that it has received patents in multiple jurisdictions, further demonstrating the Company\u2019s continued execution of expanding and protecting its Intellectual Property (IP) portfolio. The Company now has 40 issued\/allowed patents and 23 patent applications pending worldwide. \u201cAs we continue to make progress on the development, clinical and regulatory fronts, it is encouraging that we are also achieving our goals to broaden the protection of our novel technologies,\u201d commented Harel Gadot, CEO, President and Chairman. \u201cStrengthening our IP portfolio is a critical component of Microbot\u2019s strategy for facilitating product evolution and maximizing future commercial opportunities.\u201d The U.S. Patent and Trademark Office (USPTO) issued a Notice of Allowance &hellip; Continue reading \"Microbot Medical Secures Patents in Multiple Global Jurisdictions\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-secures-patents-in-multiple-global-jurisdictions\/","og_site_name":"Market Newsdesk","article_published_time":"2020-11-17T12:03:15+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NzEzNyMzODMwMTg5IzIwODIxMTE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-secures-patents-in-multiple-global-jurisdictions\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-secures-patents-in-multiple-global-jurisdictions\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Microbot Medical Secures Patents in Multiple Global Jurisdictions","datePublished":"2020-11-17T12:03:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-secures-patents-in-multiple-global-jurisdictions\/"},"wordCount":655,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-secures-patents-in-multiple-global-jurisdictions\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NzEzNyMzODMwMTg5IzIwODIxMTE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-secures-patents-in-multiple-global-jurisdictions\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-secures-patents-in-multiple-global-jurisdictions\/","name":"Microbot Medical Secures Patents in Multiple Global Jurisdictions - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-secures-patents-in-multiple-global-jurisdictions\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-secures-patents-in-multiple-global-jurisdictions\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NzEzNyMzODMwMTg5IzIwODIxMTE=","datePublished":"2020-11-17T12:03:15+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-secures-patents-in-multiple-global-jurisdictions\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-secures-patents-in-multiple-global-jurisdictions\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-secures-patents-in-multiple-global-jurisdictions\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NzEzNyMzODMwMTg5IzIwODIxMTE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA4NzEzNyMzODMwMTg5IzIwODIxMTE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-secures-patents-in-multiple-global-jurisdictions\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Microbot Medical Secures Patents in Multiple Global Jurisdictions"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/382641","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=382641"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/382641\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=382641"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=382641"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=382641"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}